Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Dynamic Health Products, Inc. Reports 2006 Revenue
Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year.
- Dynamic Health Products, Inc. Reports 2006 Revenue
Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- Galaxy Nutritional Foods Reports FY2006 Operating Results
For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year.
- Galaxy Nutritional Foods Reports FY2006 Operating Results
For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year.
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- USANA Reports Q2 Results
Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year.
- USANA Reports Q2 Results
Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year.
- Allimax Enters Australia
Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements.
- Allimax Enters Australia
Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- Whole Foods Market Reports Third Quarter Results
Company reported that sales increased 18% to $1.3 billion driven by 14% weighted average square footage growth and 9.9% comparable store sales growth, while net income increased 33% to $53.9 million, and diluted earnings per share increased 27% to $0.37.
- Whole Foods Market Reports Third Quarter Results
Company reported that sales increased 18% to $1.3 billion driven by 14% weighted average square footage growth and 9.9% comparable store sales growth, while net income increased 33% to $53.9 million, and diluted earnings per share increased 27% to $0.37.
- Nu Skin Enterprises Receives Direct Selling Authorization in Mainland China
Company has received approval from the Chinese Ministry of Commerce to commence direct selling activities in Mainland China.
- Nu Skin Enterprises Receives Direct Selling Authorization in Mainland China
Company has received approval from the Chinese Ministry of Commerce to commence direct selling activities in Mainland China.
- Nu Skin Enterprises Reports Second-Quarter 2006 Results
Company reports revenue of $284.1 million, compared to $310.1 million for the prior-year period, with net income and earnings per share for the quarter of $14.1 million and $0.20, respectively, compared to net income of $22.8 million and earnings per share of $0.32 for the same period in 2005.
- Nu Skin Enterprises Reports Second-Quarter 2006 Results
Company reports revenue of $284.1 million, compared to $310.1 million for the prior-year period, with net income and earnings per share for the quarter of $14.1 million and $0.20, respectively, compared to net income of $22.8 million and earnings per share of $0.32 for the same period in 2005.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Balchem Announces Second Quarter Earnings
Company reports net sales of $25.1 million versus $19.5 million the prior year, as the sales of the Encapsulated/Nutritional Products segment were a record $10.5 million, an increase of 55.3% from the prior year comparable quarter.
- Balchem Announces Second Quarter Earnings
Company reports net sales of $25.1 million versus $19.5 million the prior year, as the sales of the Encapsulated/Nutritional Products segment were a record $10.5 million, an increase of 55.3% from the prior year comparable quarter.
- DNP International Reports First Half and Outlook
Company observes adjusted sales increase of over 51%.
- DNP International Reports First Half and Outlook
Company observes adjusted sales increase of over 51%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Fuji Health Science, Inc., Mount Laurel, NJ announced today that its parent company, Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin.
This new patent joins other Fuji patents for astaxanthin in areas such as muscle endurance, immunomodulation, gastric health and fertility. Fuji's pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.
According to Charles DePrince, President of Fuji Health Science, Inc., "Our intellectual property is an indicator of Fuji's dedication to support the research into the benefits of astaxanthin. This support continues aggressively with our newest research involving the areas contributing to metabolic syndrome."
Fuji Chemical, producer of AstaREAL® astaxanthin, is the world's leading supplier of natural astaxanthin from the microalgae, haematococcus pluvialis. Fuji uses fully enclosed state of the art cultivation systems for astaxanthin in both Hawaii and Sweden.
For more information contact: Joseph Catalfamo
856 234 3636
catalfamo@fujihealthscience.com
- END -
|